调节DNA转录:ASO治疗的未来?
1RNA Therapeutic Institute, UMASS Chan Medical School, Worcester, MA 01581, USA.
Cell
|June 10, 2022
概括
研究人员发现,用于脊髓肌肉缩 (SMA) 的药物Nusinersen可以通过促进抑制色素修饰来阻碍其自身的有效性. 同时使用基因组脱乙酶抑制剂可以克服这一局限性,改善异构体的包容性,从而更好地治疗SMA.
科学领域:
- 遗传学和表观遗传学
- 治疗药物开发
- 神经退行性疾病
背景情况:
- 脊柱肌缩是一种严重的遗传性疾病,影响运动神经元.
- 抗意义寡核酸 (ASO) 治疗,如努辛森,是SMA的关键治疗方法.
- 努辛森通过促进在SMN2基因中的外基因包含而起作用.
研究的目的:
- 研究可能限制Nusinersen在SMA治疗中的疗效机制.
- 确定增强nusinersen治疗效益的策略.
主要方法:
- 纳西森治疗引起的染色质变化的分析.
- 压制性染色体修饰对外因子包含的影响的评估.
- 评估与努辛森同时使用的基因脱乙酶抑制剂 (HDAC).
主要成果:
- 发现努辛森治疗诱导了抑制性染色质修饰.
- 这些修改被观察到可以抵消外因子含入的预期效果.
- 同时使用HDAC抑制剂和nusinersen成功增强了外因子的含量.
结论:
- 抑制性染色质修饰是Nusinersen治疗SMA的内在限制.
- 基质脱乙酶抑制剂可以克服这一局限性,提供提高ASO有效性的策略.
- 这一发现为增强SMA的抗意义寡核酸基疗法提供了一种新方法.
相关概念视频
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Types of RNA
6.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.6K
Transcription Attenuation in Prokaryotes
16.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
16.2K
Regulation of Expression at Multiple Steps
1.1K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.1K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


